EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility and Safety of High‐Dose Proton Re‐Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single‐Institution Retrospective Study

Jin-Ho Song, Jonathan Baron iD, Carlos Chavez Perez, Sidharth Ramesh, Jane Minturn, Kavita A Desai, Amish C Shah, Jean M Belasco, Kristina A Cole iD, Michael J Fisher, Phillip B Storm, Peter M Madsen iD und 4 weitere

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Jin-Ho Song und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. Hauptthemen laut MEDLINE: Proton Therapy, Re-Irradiation, Central Nervous System Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Pediatric central nervous system (CNS) tumors often recur despite multimodality therapy. Although re‐irradiation (re‐RT) has historically been limited by concerns for severe late toxicities, modern techniques have renewed interest in this approach. Proton therapy provides dosimetric advantages that may enable curative re‐treatment with reduced normal tissue exposure.

Methods

We retrospectively reviewed 54 pediatric patients who underwent proton re‐RT for recurrent CNS tumors at our institution (2010–2024). Eligible patients had received prior CNS‐directed RT at ≤20 years of age. Toxicities were graded per Common Terminology Criteria for Adverse Events (CTCAE) v5.0 as acute (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyRe-IrradiationCentral Nervous System NeoplasmsNeoplasm Recurrence, LocalHumansChildFemaleRetrospective StudiesMaleAdolescentChild, PreschoolFeasibility StudiesInfantRadiotherapy DosageSurvival RateFollow-Up StudiesPrognosisYoung Adult

Stichwörter der Autor:innen

neuro‐oncologypediatric CNS tumorsproton therapyradiation oncologyre‐irradiation

Autor:innen und Institutionen

  • Department of Radiation Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Jonathan Baron, Kristina A Cole, Peter M Madsen

Zitieren

APA

Song, J. H., Baron, J., Perez, C. C., Ramesh, S., Minturn, J., Desai, K. A., Shah, A. C., Belasco, J. M., Cole, K. A., Fisher, M. J., Storm, P. B., Madsen, P. M., Kurtz, G., Lustig, R. A., Hill-Kayser, C., & LaRiviere, M. J. (2026). Feasibility and Safety of High‐Dose Proton Re‐Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single‐Institution Retrospective Study. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70371

Vancouver

Song JH, Baron J, Perez CC, Ramesh S, Minturn J, Desai KA, et al. Feasibility and Safety of High‐Dose Proton Re‐Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single‐Institution Retrospective Study. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70371

BibTeX
@article{Song2026,
  author = {Song, Jin-Ho and Baron, Jonathan and Perez, Carlos Chavez and Ramesh, Sidharth and Minturn, Jane and Desai, Kavita A and Shah, Amish C and Belasco, Jean M and Cole, Kristina A and Fisher, Michael J and Storm, Phillip B and Madsen, Peter M and Kurtz, Goldie and Lustig, Robert A and Hill-Kayser, Christine and LaRiviere, Michael J},
  title = {Feasibility and Safety of High‐Dose Proton Re‐Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single‐Institution Retrospective Study},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70371}
}
Kostenlos starten →